Baclofen Dosing for Cough
Baclofen is not recommended for routine cough suppression based on current evidence-based guidelines, which explicitly state that drugs affecting the efferent limb of the cough reflex (including baclofen) should not be used for chronic or acute cough requiring symptomatic relief. 1, 2
Guideline Position
The ACCP evidence-based clinical practice guidelines provide a Grade D recommendation (Level of evidence: low; benefit: none) against using drugs that affect the efferent limb of the cough reflex, which includes baclofen as a GABA-agonist muscle relaxant 1, 2. These guidelines prioritize:
- For chronic bronchitis: Central cough suppressants (codeine, dextromethorphan) or peripheral suppressants (levodropropizine, moguisteine)
- For URI/bronchitis: Ipratropium bromide as the only recommended inhaled anticholinergic
Research Evidence Context
Despite the guideline recommendation against baclofen, several small studies have explored its off-label use:
Dosing Regimens Used in Research Studies:
For ACE-inhibitor induced cough 3:
- 5 mg three times daily for days 1-7
- 10 mg three times daily for days 8-28
- All 7 patients showed improvement by mean 4 days, with persistent suppression lasting 25-74 days after discontinuation
For general chronic refractory cough 4, 5:
- 10 mg three times daily for 14 days
- Demonstrated significant elevation in capsaicin cough threshold in normal subjects
- 6 of 10 subjects showed ≥4-fold increase in cough threshold
For GERD-induced chronic cough 6:
- 20 mg three times daily for 8 weeks (as add-on to omeprazole)
- 56.3% response rate (9/16 patients)
- Cough improvement began at week 2, clearly decreased at week 6
- Main adverse effects: somnolence, dizziness, fatigue
Critical Caveats
The FDA-approved dosing for baclofen's indicated use (spasticity) differs significantly 7:
- Standard titration: 5 mg TID → 10 mg TID → 15 mg TID → 20 mg TID (each for 3 days)
- Maximum daily dose: 80 mg/day (20 mg QID)
- This is for spasticity, NOT cough
Important safety considerations:
- Baclofen carries risk of sedation, dizziness, and fatigue
- Abrupt withdrawal can cause serious complications
- The studies cited used much lower doses (10-20 mg TID) than maximum approved dosing
Clinical Algorithm
If considering baclofen for refractory cough despite guideline recommendations:
First exhaust guideline-recommended options 1, 2:
- Identify and treat underlying cause
- For chronic bronchitis: codeine or dextromethorphan
- For URI/bronchitis: ipratropium bromide
- Rule out asthma (albuterol not recommended for non-asthmatic cough)
If truly refractory and considering off-label baclofen:
- Start: 5-10 mg three times daily
- Duration: 2-4 weeks minimum for effect
- Monitor for sedation, dizziness, fatigue
- Consider higher doses (20 mg TID) only for GERD-related cough with concurrent PPI therapy 6
Do not use baclofen for:
- Acute URI-related cough
- First-line therapy for any cough
- Patients requiring alertness for safety-sensitive activities
The evidence base for baclofen in cough consists only of small, uncontrolled studies and case reports 3, 6, 4, 5, which is insufficient to override the guideline recommendation against its use. The most prudent approach is to follow evidence-based guidelines and reserve baclofen only for exceptional cases of refractory cough after documented failure of recommended therapies.